Immuno Natural Oils Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-07-2024
- Paid Up Capital ₹ 0.60 M
as on 06-07-2024
- Company Age 42 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.60 Cr
as on 06-07-2024
- Satisfied Charges ₹ 1.70 M
as on 06-07-2024
- Revenue -25.94%
(FY 2023)
- Profit -13.62%
(FY 2023)
- Ebitda 7.37%
(FY 2023)
- Net Worth 21.53%
(FY 2023)
- Total Assets -0.44%
(FY 2023)
About Immuno Natural Oils
The Corporate was formerly known as B.K. Castings Pvt Ltd. The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹3.60 Cr. The company has closed loans amounting to ₹1.70 M, as per Ministry of Corporate Affairs (MCA) records.
Praneeta Jilhewar and Milind Jilhewar serve as directors at the Company.
- CIN/LLPIN
U15140MP1982PTC002031
- Company No.
002031
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 1982
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Mandsaur, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Immuno Natural Oils?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praneeta Jilhewar  | Director | 28-Dec-2011 | Current |
| Milind Jilhewar | Director | 29-Jan-2010 | Current |
Financial Performance of Immuno Natural Oils.
Immuno Natural Oils Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 25.94% decrease. The company also saw a substantial fall in profitability, with a 13.62% decrease in profit. The company's net worth Soared by an impressive increase of 21.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Immuno Natural Oils?
In 2023, Immuno Natural Oils had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Garlico Herbal Private LimitedActive 13 years 11 monthsPraneeta Jilhewar and Milind Jilhewar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Feb 2024 | ₹1.10 Cr | Open |
Others Creation Date: 26 Feb 2024 | ₹1.50 Cr | Open |
Others Creation Date: 20 May 2020 | ₹1.00 Cr | Open |
How Many Employees Work at Immuno Natural Oils?
Unlock and access historical data on people associated with Immuno Natural Oils, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Immuno Natural Oils, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Immuno Natural Oils's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
